DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) — all Canadian products
9 DINs
3 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02242010 | DOBUTAMINE INJECTION USP | SANDOZ CANADA INCORPORATED | Liquid | Intravenous | DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) 12.5 MG | Marketed | |
| 02462729 | DOBUTAMINE INJECTION USP | HIKMA CANADA LIMITED | Solution | Intravenous | DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) 12.5 MG | Marketed | |
| 02443430 | DOBUTAMINE INJECTION USP | STERIMAX INC | Solution | Intravenous | DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) 12.5 MG | Approved | |
| 02229451 | DOBUTAMINE 12.5MG/ML | IVAX PHARMACEUTICALS INCORPORATED | Solution | Intravenous | DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) 12.5 MG | Cancelled Post Market | |
| 02228335 | DOBUTAMINE HYDROCHLORIDE INJECTION-12.5MG/ML | NOVOPHARM LIMITED | Liquid | Intravenous | DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) 12.5 MG | Cancelled Post Market | |
| 02225891 | DOBUTAMINE HYDROCHLORIDE INJECTION-12.5MG/ML | SANOFI CANADA, INC. | Liquid | Intravenous | DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) 12.5 MG | Cancelled Post Market | |
| 02384671 | DOBUTAMINE INJECTION SDZ | SANDOZ CANADA INCORPORATED | Solution | Intravenous | DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) 12.5 MG | Dormant | |
| 02210401 | DOBUTAMINE INJECTION USP | PFIZER CANADA ULC | Solution | Intravenous | DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) 250 MG | Cancelled Post Market | |
| 00759538 | DOBUTREX | PHARMACEUTICAL PARTNERS OF CANADA INC | Solution | Intravenous | DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) 12.5 MG | Cancelled Post Market |
Browse other molecules: